Journal Information

Special content about coronavirus SARS-CoV-2 (COVID-19) in Hematology, Transfusion and Cell Therapy

Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia
Arthur Gomes Oliveira Braga, Katia Borgia Barbosa Pagnano, Marina Dal'Bó Pelegrini Campioni, Ana Beatriz Pascoal Lopes, Gislaine Oliveira Duarte, Konradin Metze, Irene Lorand-Metze
10.1016/j.htct.2023.06.001
Hematol Transfus Cell Ther. 2024;46:268-72
Full text access
Oligosymptomatic infection by SARS-Cov-2 in catastrophic antiphospholipid syndrome, a singular coincidence: a case report in an Ecuadorian hospital
Jorge Luis Vélez-Páez, Jhonny Manuel Carranza-Jara, Doryz Catalina Almeida-Posso, Steven S. Witkin, Cesar de Almeida-Neto
10.1016/j.htct.2023.06.002
Hematol Transfus Cell Ther. 2024;46:316-20
Full text access
Prevalence of anti-HLA antibodies in COVID-19 convalescent plasma donors: an Indian experience
Ram Jaiswal, Aseem Kumar Tiwari, Ashina Singla, Ashish Jain, Rajaat Vohra, Munish Kakkar, Prashanth Suravajhala
10.1016/j.htct.2024.03.003
Full text access
Uncorrected Proof. Available online 29 April 2024
2 - Anuncio Acreditacao
10.1016/S2531-1379(24)00217-7
Hematol Transfus Cell Ther. 2024;46 Supl 1:v
Full text access
COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality –cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM)
Marcia Garnica, Edvan De Queiroz Crusoe, Glaciano Ribeiro, Rosane Bittencourt, Roberto José Pessoa Magalhães, Karla Richter Zanella, Abrahão Elias Hallack Neto, Juliana Souza Lima, Caroline Bonamin Solo, Emmanuella Graciott Souza, Andre Magalhaes Fernandes, Angelo Maiolino, Vania Hungria
10.1016/j.htct.2023.08.002
Hematol Transfus Cell Ther. 2024;46:153-60
Full text access
Extracellular vesicles are a late marker of inflammation, hypercoagulability and COVID-19 severity
Bárbara Gomes Barion, Tania Rubia Flores da Rocha, Yeh-Li Ho, Bruna de Moraes Mazetto Fonseca, Erica Okazaki, Cynthia Rothschild, Bianca Stefanello, Vanderson Geraldo Rocha, Paula Ribeiro Villaça, Fernanda A. Orsi
10.1016/j.htct.2023.12.003
Hematol Transfus Cell Ther. 2024;46:176-85
Full text access
DOES PET/CT WITH 18F-FLUOROESTRADIOL (18F-FES) CONTRIBUTE TO THE ASSESSMENT OF BREAST CANCER COMPARED TO FLUORINE-2-D-DEOXYGLUCOSE (18F-FDG)?
Bruno Russiano de Oliveira Boeno, Yuri Aguillera Pedreira, Marcelo Moreira da Silva, Carla Lima Santos Viviani, Leonardo Fonseca Monteiro do Prado
10.1016/j.htct.2024.04.078
Hematol Transfus Cell Ther. 2024;46 Supl 2:S18-9
Full text access
Anti-PF4 antibodies and their relationship with COVID infection
Chieh Yang, Irene Wang, Akshit Chitkara, Jibin Swankutty, Rushin Patel, Samir V Kubba
10.1016/j.htct.2023.11.012
Full text access
Available online 21 February 2024
Thrombocytopenic thrombotic purpura related to COVID-19 vaccine: apropos of 4 cases
Célia Dos Santos, Santiago Castera, José Fernandez, Julieta Soledad Rosales, Franco Crescitelli, Santiago Boughen, Marcelo Iastrebner, Osvaldo Guerrero, Carlos Amell Menco, Mariela Gomez, Jacqueline Gonzalez, Maria Fabiana Alberto, Analía Sanchez-Luceros
10.1016/j.htct.2023.11.008
Full text access
Available online 16 January 2024
Spontaneous remission without treatment of acute myelomonocytic leukemia associated with COVID-19 infection
Rafael Peñuela, Indira Hernandez, Mónica Fernandes-Pineda, Lázaro Cortina, Diana Zapata, Olga Urrego, Juan Herrera, Isabel Saenz, Recio Orduz, Fabián Mejia, Liliana Moreno, Margarita Velazco
10.1016/j.htct.2023.11.004
Full text access
Available online 9 January 2024
Idiomas
Hematology, Transfusion and Cell Therapy